Superficial Basal cell carcinoma
Conditions
Brief summary
Complete remission (CR) of BCC at the end of treatment. CR is defined as the absence of evidence of BCC clinically and on LC-OCT.
Detailed description
Type, frequency, severity and time of onset of side effects. Side effects will be classified into grades based on the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) scale. The intensity of short-term local side effects will be assessed using the LSR score., Complete remission of BCCs after 1, 2, 3, or 4 cycles of treatment., LC-OCT measurement of BCC thickness., TSQM9 score.
Interventions
Sponsors
Centre Hospitalier Universitaire De Nice
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete remission (CR) of BCC at the end of treatment. CR is defined as the absence of evidence of BCC clinically and on LC-OCT. | — |
Secondary
| Measure | Time frame |
|---|---|
| Type, frequency, severity and time of onset of side effects. Side effects will be classified into grades based on the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) scale. The intensity of short-term local side effects will be assessed using the LSR score., Complete remission of BCCs after 1, 2, 3, or 4 cycles of treatment., LC-OCT measurement of BCC thickness., TSQM9 score. | — |
Countries
France
Outcome results
None listed